INHIBITRON Trademark

Trademark Overview

On Thursday, January 3, 2019, a trademark application was filed for INHIBITRON with the United States Patent and Trademark Office. The USPTO has given the INHIBITRON trademark a serial number of 88247800. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 8, 2021. This trademark is owned by LABORATORIOS LIOMONT, S.A. DE C.V.. The INHIBITRON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, proton-pump inhibitors
inhibitron

General Information

Serial Number88247800
Word MarkINHIBITRON
Filing DateThursday, January 3, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 8, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, proton-pump inhibitors

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 24, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLABORATORIOS LIOMONT, S.A. DE C.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMexico City 05000
MX
Party NameLABORATORIOS LIOMONT, S.A. DE C.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMexico City 05000
MX

Trademark Events

Event DateEvent Description
Wednesday, May 4, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 4, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 4, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 4, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 22, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 8, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 8, 2021ABANDONMENT - NO USE STATEMENT FILED
Monday, December 21, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, December 21, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 21, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, December 21, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 21, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 21, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 4, 2020SOU EXTENSION 2 GRANTED
Tuesday, February 4, 2020SOU EXTENSION 2 FILED
Tuesday, February 4, 2020TEAS EXTENSION RECEIVED
Tuesday, August 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 10, 2019SOU EXTENSION 1 GRANTED
Saturday, August 10, 2019SOU EXTENSION 1 FILED
Saturday, August 10, 2019TEAS EXTENSION RECEIVED
Tuesday, July 2, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 7, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 21, 2019ASSIGNED TO EXAMINER
Thursday, January 24, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 7, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

inhibitron pump inhibitors proton namely preparations pharmaceutical